Literature DB >> 22484457

Cryoglobulinemia (review).

Shimon Takada1, Taro Shimizu, Yoshiro Hadano, Kentaro Matsumoto, Yuki Kataoka, Yu Arima, Toshiya Inoue, Sumire Sorano.   

Abstract

Cryoglobulins are immunoglobulins that precipitate at low temperatures and redissolve upon rewarming. Cryoglobulinemia refers to the presence of circulating cryoglobulins in serum, and generally leads to a systemic inflammatory syndrome characterized by fatigue, arthralgia, purpura, neuropathy and glomerulonephritis. The disease mainly involves small to medium-sized blood vessels and causes vasculitis due to cryoglobulin-containing immune complexes. Cryoglobulinemia is classified into three types (I, II and III) on the basis of immunoglobulin composition. Predisposing conditions include lymphoproliferative disease, collagen disease and hepatitis C virus (HCV) infection. The diagnosis of cryoglobulinemic syndrome is predominantly based on the laboratory demonstration of serum cryoglobulins. Treatment is often directed towards the underlying disease state. For patients with chronic HCV infection, anti-viral therapy is indicated. Intense immunosuppressive or immunomodulatory therapy, including steroids, plasmapheresis and cytotoxic agents, is reserved for organ-threatening or recalcitrant disease. In this review, we discuss the clinical characteristics of the three types of cryoglobulinemia.

Entities:  

Mesh:

Year:  2012        PMID: 22484457     DOI: 10.3892/mmr.2012.861

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

Review 1.  Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.

Authors:  Mariana Ciocchini; Jorge Arbelbide; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2017-04-19       Impact factor: 2.370

2.  Extensive choroidal infarction in a case of mixed essential cryoglobulinaemia in a postpartum female.

Authors:  Brijesh Takkar; Shorya Vardhan Azad; Uma Kumar; Pradeep Venkatesh
Journal:  BMJ Case Rep       Date:  2016-09-16

3.  Pulmonary hemorrhage in cryoglobulinemia.

Authors:  Gordon Kirkpatrick; Tiffany Winstone; Pearce Wilcox; Stephan Van Eeden
Journal:  Can Respir J       Date:  2014-12-10       Impact factor: 2.409

4.  Clinicopathological features of cryoglobulinemic glomerulonephritis associated with HBV infection: a retrospective analysis of 8 cases in China.

Authors:  Chen Wang; Zi-Yin Ye; De-Hua Zeng; Fei-Lai Xie; Li-Juan Qu; Zhi-Yong Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Fulminant type I cryoglobulinemic glomerulonephritis with unique ultrastructural plugs: a case report.

Authors:  Qinjie Weng; Jing Xu; Pingyan Shen; Tian Xu; Chenni Gao; Jingyuan Xie; Hong Ren; Xiaoxia Pan
Journal:  Int J Hematol       Date:  2021-07-24       Impact factor: 2.490

6.  Cryoglobulins as potential triggers of inflammation in schizophrenia.

Authors:  Andranik Chavushyan; Meri Hovsepyan; Anna Boyajyan
Journal:  Schizophr Res Treatment       Date:  2013-12-15

7.  Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection.

Authors:  Federica Romitelli; Leopoldo Paolo Pucillo; Umberto Basile; Enrico Di Stasio
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

8.  A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Hui-Ching Hsu; Yi-Ching Weng; Ai-Lun Lo; Kuo-Hsuan Chang; Hong-Shiu Chang; Hung-Chou Kuo; Chin-Chang Huang; Long-Sun Ro
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 9.  Utility of immunologic testing in suspected rheumatologic disease.

Authors:  Monica Bhagat; Shiv T Sehra; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.919

10.  A case of malignancy-associated cryoglobulinemia.

Authors:  C Kennedy; R Doyle; N Mayer; M Clarkson
Journal:  Case Rep Nephrol Urol       Date:  2013-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.